Next-Generation Fighter Jets?!? (Must See)
The U.S. Department of Defense is using one shocking company to develop breakthrough tech...And at less than $2... this could be the last bargain on the market.

Get the Details Here (Act Fast... a Key Announcement in December Could Send It Rocketing)
>>>
pixel

BIOR Insider Trading

Insider Ownership Percentage: 30.81%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $4,585.37

Biora Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Biora Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Biora Therapeutics Share Price & Price History

Current Price: $0.25
Price Change: Price Increase of +0.0126 (5.20%)
As of 12/2/2022 09:59 PM ET

This chart shows the closing price history over time for BIOR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Biora Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/5/2022Surbhi SarnaDirectorSell7,517$0.61$4,585.37148,774View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Biora Therapeutics (NASDAQ:BIOR)

26.47% of Biora Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BIOR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Biora Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2022Neuberger Berman Group LLC6,541,060$3.17M0.0%N/A3.505%Search for SEC Filing on Google Icon
11/15/2022State Street Corp439,347$0.21M0.0%N/A0.235%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.5,897,707$2.86M0.0%N/A3.160%Search for SEC Filing on Google Icon
11/15/2022Bank of New York Mellon Corp56,455$27K0.0%N/A0.030%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.1,626,853$0.79M0.0%N/A0.872%Search for SEC Filing on Google Icon
11/15/2022Commonwealth Equity Services LLC130,034$63K0.0%N/A0.070%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Biora Therapeutics logo
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ingestible capsule for needle-free delivery of biotherapeutics directly into the intestinal mucosa for enhanced systemic uptake. It is also developing diagnostics devices to help characterize the GI tract and diagnose GI diseases, such as small intestine bacterial overgrowth through the development of various technologies to diagnose at the site of the disease. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.
Read More on Biora Therapeutics

Today's Range

Now: $0.25
Low: $0.24
High: $0.26

50 Day Range

MA: $0.36
Low: $0.23
High: $0.53

52 Week Range

Now: $0.25
Low: $0.21
High: $3.05

Volume

1,046,100 shs

Average Volume

4,315,624 shs

Market Capitalization

$56.84 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.78

Who are the company insiders with the largest holdings of Biora Therapeutics?

Biora Therapeutics' top insider investors include:
  1. Surbhi Sarna (Director)
Learn More about top insider investors at Biora Therapeutics.

Who are the major institutional investors of Biora Therapeutics?

Biora Therapeutics' top institutional shareholders include:
  1. Neuberger Berman Group LLC — 3.50%
  2. Vanguard Group Inc. — 3.16%
  3. BlackRock Inc. — 0.87%
  4. State Street Corp — 0.24%
  5. Commonwealth Equity Services LLC — 0.07%
  6. Citadel Advisors LLC — 0.00%
Learn More about top institutional investors of Biora Therapeutics stock.

Which major investors are buying Biora Therapeutics stock?

Within the last quarter, BIOR stock was acquired by institutional investors including:
  1. Neuberger Berman Group LLC
  2. Vanguard Group Inc.
  3. BlackRock Inc.
  4. State Street Corp
  5. Commonwealth Equity Services LLC
  6. Citadel Advisors LLC
  7. Bank of New York Mellon Corp
  8. Jane Street Group LLC
Our Top 5 Microcap Stocks
Microcap stocks tend to be an under-researched area… Which increases the odds of discovering attractive investment opportunities.

Just like these 5 which appear to be in an excellent position to see a surge in share price.
>>> See All 5 Here
pixel